Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT

NCT00350181

Conditions: Acute GVHD, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma

NCT00299182

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT

NCT03018223

Conditions: Acute Leukemia in Remission, Blood Protein Disorders, Bone Marrow Diseases, +35 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases

NCT00424242

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +112 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma

NCT00052442

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +23 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Evaluate the Safety and Efficacy of TGR 1202 in Patients With Relapsed or Refractory Hematologic Malignancies

NCT01767766

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +22 more
Locations: TG Therapeutics Trial Site Sarasota, Florida, United States

TG Therapeutics Trial Site Hackensack, New Jersey, United States

TG Therapeutics Trial Site New York, United States

TG Therapeutics Trial Site Durham, North Carolina, United States

View Trial Details

Completed

Treatment of Non-Hodgkin's Lymphoma With 90Y-hLL2 IgG

NCT00061425

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Not specified

View Trial Details

Completed

Safety Study of Different Doses of hA20 (Veltuzumab) in CD20+ Non-Hodgkin's Lymphoma

NCT00596804

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
Locations: Service Des Maladies Du Sang Lille, Cedex, France

Centre hospitalier Lyon Lyon, Pierre Benite Cedex, France

University of Leicester Leicester, United Kingdom

View Trial Details

Completed

Study of hA20 (Humanized Anti-CD20) in Patients With CD20+ Non-Hodgkin's Lymphoma

NCT00285428

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: New York Presbyterian Hospital/Cornell Medical Center New York, United States

University Hospital of Pennsylvania Philadelphia, Pennsylvania, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Polatuzumab Vedotin in Patients With Relapsed and Refractory Diffuse Large B Cell Lymphoma

NCT05006534

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions